Greatbatch wins $37.5 million in pacemaker dispute
Delaware | 28 January 2016

Medical device company Greatbatch has won $37.5 million in damages after a jury confirmed the validity of its patents on implantable pacemakers.

The US District Court for the District of Delaware jury returned a verdict on 26 January that rivals AVX Corp and AVX Filters infringed two of Greatbatch’s patents.

Thomas Hook, president of Greatbatch, said in a statement that the jury’s decision marked an important milestone in its effort to defend its patented technology.

Greatbatch sued AVX in April 2013 for selling filtered feedthrough assemblies used in implantable pacemakers and cardioverter defibrillators that infringed its patents.

Ending the three-year dispute, the Delaware jury ruled that AXV did infringe Greatbatch’s patents and rejected all of AVX’s defences.

In awarding $37.5 million in damages, the jury also confirmed the validity of Greatbatch’s asserted patents, as well as two other patents that AVX had challenged.

“Greatbatch is committed to challenging willful and deliberate patent infringement and to taking all steps necessary to ensure that our IP is protected,” added Hook.

Author: Tammy Facey

More IPPro Life Sciences | latest news
AstraZeneca enters China with Plendil
Hogan Lovells boosts capabilities in Japan
Morgan Lewis bags four from K&L Gates
Cobra and CPI enter £1.8 million project
Doctors Without Borders urges lower vaccine prices
IPPro Life Sciences


Copyright (C) 2013 Black Knight Media Ltd. All rights reserved. No reproduction without prior authorization